JP2011505361A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505361A5
JP2011505361A5 JP2010536091A JP2010536091A JP2011505361A5 JP 2011505361 A5 JP2011505361 A5 JP 2011505361A5 JP 2010536091 A JP2010536091 A JP 2010536091A JP 2010536091 A JP2010536091 A JP 2010536091A JP 2011505361 A5 JP2011505361 A5 JP 2011505361A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
represented
formula
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010536091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011505361A (ja
JP5566902B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/084495 external-priority patent/WO2009073432A1/en
Publication of JP2011505361A publication Critical patent/JP2011505361A/ja
Publication of JP2011505361A5 publication Critical patent/JP2011505361A5/ja
Application granted granted Critical
Publication of JP5566902B2 publication Critical patent/JP5566902B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010536091A 2007-11-29 2008-11-24 プロスタグランジン活性を有する置換シクロペンタン類 Expired - Fee Related JP5566902B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99100307P 2007-11-29 2007-11-29
US60/991,003 2007-11-29
PCT/US2008/084495 WO2009073432A1 (en) 2007-11-29 2008-11-24 Substituted cyclopentanes having prostaglandin activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014125190A Division JP2014221776A (ja) 2007-11-29 2014-06-18 プロスタグランジン活性を有する置換シクロペンタン類

Publications (3)

Publication Number Publication Date
JP2011505361A JP2011505361A (ja) 2011-02-24
JP2011505361A5 true JP2011505361A5 (enExample) 2012-01-19
JP5566902B2 JP5566902B2 (ja) 2014-08-06

Family

ID=40456785

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010536091A Expired - Fee Related JP5566902B2 (ja) 2007-11-29 2008-11-24 プロスタグランジン活性を有する置換シクロペンタン類
JP2014125190A Abandoned JP2014221776A (ja) 2007-11-29 2014-06-18 プロスタグランジン活性を有する置換シクロペンタン類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014125190A Abandoned JP2014221776A (ja) 2007-11-29 2014-06-18 プロスタグランジン活性を有する置換シクロペンタン類

Country Status (7)

Country Link
US (2) US8158676B2 (enExample)
EP (1) EP2231162A1 (enExample)
JP (2) JP5566902B2 (enExample)
AU (1) AU2008331597B2 (enExample)
BR (1) BRPI0819707A2 (enExample)
CA (1) CA2706879A1 (enExample)
WO (1) WO2009073432A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof
CN109072186B (zh) 2016-03-04 2023-06-23 莱兰斯坦福初级大学评议会 利用前列腺素e2进行肌肉再生的组合物和方法
WO2018227134A1 (en) 2017-06-09 2018-12-13 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for preventing or treating muscle conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259516A (en) * 1979-04-02 1981-03-31 The Upjohn Company 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6090847A (en) * 1997-11-21 2000-07-18 Allergan Sales, Inc. EP2 -receptor agonists as neuroprotective agents for the eye
US7091231B2 (en) 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
BRPI0605926A2 (pt) * 2005-01-14 2009-05-26 Allergan Inc ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7476755B2 (en) * 2006-05-04 2009-01-13 Allergan, Inc. Therapeutic compounds
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
EP2288385A2 (en) * 2008-04-16 2011-03-02 Allergan, Inc. Combination therapy for glaucoma

Similar Documents

Publication Publication Date Title
JP2009114217A5 (enExample)
JP2011500818A5 (enExample)
JP2009543795A5 (enExample)
JP2010534247A5 (enExample)
JP2010280669A5 (enExample)
JP2010500976A5 (enExample)
JP2009543794A5 (enExample)
JP2010518128A5 (enExample)
JP2011527691A5 (enExample)
JP2008543854A5 (enExample)
JP2014509612A5 (enExample)
JP2009535426A5 (enExample)
JP2010500416A5 (enExample)
JP2010540477A5 (enExample)
JP2009541224A5 (enExample)
RU2014105895A (ru) Терапевтические замещенные циклопентаны для уменьшения внутриглазного давления
JP2011505361A5 (enExample)
JP2012177087A5 (enExample)
JP2019507105A5 (enExample)
RU2012144438A (ru) Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза
JP2013513607A5 (enExample)
JP2011503089A5 (enExample)
JP2011526896A5 (enExample)
JP2010516779A5 (enExample)
JP2010510263A5 (enExample)